Evaluation of the efficacy of several sclerosing agents for pleurodesis in rats
Objective: This study aims to evaluate the efficiencies and effects of different sclerosing agents. Materials and Methods: Thirty-five female Wistar-albino rats were included in this study and divided into five groups randomly. Isotonic saline (group 1), iodopovidone (group 2), rifamycin (group 3), autologous blood (group 4), talc (group 5) were given into intrapleural space. On postoperative 28th day, ipsilateral and contralateral pleural and parenchymal fibrosis and inflammation were evaluated. Results: There were statistically differences between control and other groups on macroscopically pleural fibrosis examination (p=0.004, p=0.001, p=0.001, p=0.000, respectively). Microscopically pleural fibrosis were determined in all groups when compared to control group (p=0.023, p=0.023, p=0.035, p=0.001, respectively). There were no significant differences between sclerosing agent groups (p>0.05). Significant differences were observed according to microscopic pleural inflammation evaluation between talc group and other groups. There was superiority in talc group according to intraparenchymal inflammation grade compared to other groups (p=0.010, p=0.042, p=0.030, respectively). Macroscopically, fibrosis and microscopically, inflammation were significantly observed between talc and other groups in the contralateral pleura (p = 0.037and p=0.009, respectively). Conclusion: Iodopovidone, autologous blood, talc, and rifamycin can be used as effective pleurodesis agents. However, we found that rifamycin and autologous blood are safer as effective pleurodesis agents. We think that these two agents can be used in patients with secondary lung diseases due to their less intraparenchymal inflammation rates. It may be advantageous to prefer other sclerosing agents which has lower costs and less side effects comparing to talc.
___
- Light RW, Vargas FS. Pleural sclerosis for the treatment of
pneumothorax and pleural effusion. Lung 1997;175:213-23.
- Ozpolat B, Gazyagci S, Gözübüyük A, Ayva S, Atinkaya C.
Autologous blood pleurodesis in rats to elucidate the amounts
of blood required for reliable and reproducible results. J Surg
Res 2010:15;161:228-32. doi: 10.1016/j.jss.2009.01.027.
- Teixeira LR, Vargas FS, Acencio MM, Bumlai RU, Antonangelo
L, Marchi E. Experimental pleurodesis induced by antibiotics
(macrolides or quinolones). Clinics 2006;61:559-64.
- Ahn HY, Cho JS, Kim YD, et al. Efficacy of mistletoe for
chemical pleurodesis in rats without malignancy. Open Med
(Wars) 2015:4;10:346-51. doi: 10.1515/med-2015-0051.
- Light RW, Wang NS, Sassoon CS, Gruer SE, Vargas FS. Talc
slurry is an effective pleural sclerosant in rabbits. Chest
1995;107:1702-6.
- Arifin WN, Zahiruddin WM. Sample size calculation in
animal studies using resource equation approach. Malays J
Med Sci 2017; 24: 101-5. doi: 10.21315/mjms2017.24.5.11.
- Mitchem RE, Herndon BL, Fiorella RM, Molteni A, Battie CN,
Reisz GR. Pleurodesis by autologous blood, doxycycline, and
talc in a rabbit model. Ann Thorac Surg 1999;67:917-21.
- Robinson CLN. Autologous blood for pleurodesis in recurrent
and chronic spontaneous pneumothorax. Can J Surg
1987;30:428-9.
- Lang-Lazdunski L, Coonar AS. A prospective study of
autologous ‘blood patch’ pleurodesis for persistent air
leak after pulmonary resection. Eur J Cardiothorac Surg
2004;26:897-900.
- Droghetti A, Schiavini A, Muriana P, et al. Autologous blood
patch in persistent air leaks after pulmonary resection. J
Thorac Cardiovasc Surg 2006;132:556-9.
- Bethune N. Pleural poudrage: new technique for deliberate
production of pleural adhesions as preliminary to lobectomy.
J Thorac Surg 1935; 4:251-61.
- Rehse DH, Aye RW, Florence MG. Respiratory failure
following talc pleurodesis. Am J Surg 1999;177:4:437-40.
- Yildirim H, Metintas M, Ucgun I, Erginel S, Alatas F, Kurt
E. Talc Plörodezise bağlı gelişen yan etkiler. Osman Gazi Tıp
Dergisi 2005;27:51-6.
- Werebe EC, Pazetti R, Milanez de Campos JR, et al. Systemic
distribution of talc after intrapleural administration in rats.
Chest 1999;115:190-3.
- Yalçınkaya S, Yalçınkaya U. Non-steroid anti-inflammatory
drugs reduce the efficacy of autologous blood pleurodesis.
Turk Gogus Kalp Dama 2019;27:343-9. doi: 10.5606/tgkdc.
dergisi.2019.17544
- Yazicioglu A, Uysal S, Sahinoglu T, Subasi M, Demirag F,
Yekeler E. Does sericin, as a novel pleurodesis agent, have
higher effectiveness compared to talcum powder, doxycycline,
and silver nitrate pleurodesis? Arch Bronconeumol
2019;55:357-67. doi: 10.1016/j.arbres.2018.10.003.
- Gözübüyük A, Ozpolat B, Ciçek AF, et al. Comparison of side
effects of oxytetracycline and talc pleurodesis: an experimental
study. J Cardiothorac Surg 2010:13;5:128. doi: 10.1186/1749-
8090-5-128.
- Dongel İ, Sunam GS, Külahçı Ö, Ceran S. A comparison of the
efficacies of heterologous blood, rifamycin, and talc as pleural
sclerosants in rabbits: An experimental study. Turk Gogus
Kalp Dama 2012;20:590-95.
- Echavarría A, Pinzón V, Barés JP, Fernández E. Intracavitary
treatment of malignant pleural effusion with iodine-povidone.
Rev Med Panama 1991;16:69-74.
- Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Efficacy and
safety of iodopovidone in chemical pleurodesis: A metaanalysis
of observational studies. Respir Med 2006;100:2043-
7, doi:http://dx.doi.org/10.1016/j.rmed.2006.02.009.
- Bagheri R, Noori M, Rajayi M, et al. The effect of
iodopovidone versus bleomycin in chemical pleurodesis.
Asian Cardiovasc Thorac Ann 2018;26:382-386. doi:
10.1177/021.849.2318778485.
- Ibrahim IM, Dokhan AL, El-Sessy AA and Eltaweel MF.
Povidone-iodine pleurodesis versus talc pleurodesis in preventing
recurrence of malignant pleural effusion. J Cardiothorac Surg
2015;1;10:64. doi: 10.1186/s13019.015.0270-5.
- Bryant WP, Zimmerman D. Iodine-induced hyperthyroidism
in a newborn. Pediatrics. 1995;95:434-6. Erratum in: Pediatrics
1995;96:779.
- Yeginsu A, Karamustafaoglu A, Ozugurlu F. Etikan I.
Iodopovidone pleurodesis does not effect thyroid function in
normal adults. Interact Cardiovasc Thorac Surg 2007;6: 563-4.